Ginkgo Bioworks Holdings (United States) is listed on the Nasdaq and has a market capitalization of $760.66 million, with shareholders equity totaling $420.28 million.
The company employs approximately 485 people and operates in the Others sector, within the Others industry.
Over the past 12 months, Ginkgo Bioworks Holdings reported $132.42 million in revenue, generating net income of $-290.80 million.
Key financial metrics include a P/E ratio of -2.62, a price-to-book (P/B) ratio of 1.81, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker DNA.